<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00363792</url>
  </required_header>
  <id_info>
    <org_study_id>KA-20060085</org_study_id>
    <nct_id>NCT00363792</nct_id>
  </id_info>
  <brief_title>Effect of GTN and Diamox Measured by BOLD-Response.</brief_title>
  <official_title>The Effect of Glyceryl Trinitrate and Diamox on Blood-Oxygenation-Level-Dependent.Signal (BOLD-Signal) and Cerebral Haemodynamics With the Use of a 3-Tesla MRI-Scan.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Headache Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danish Headache Center</source>
  <brief_summary>
    <textblock>
      In healthy subjects different cerebral haemodynamic values wished to be determined after&#xD;
      infusion of the NO donor Glyceryl trinitrate (GTN) and Diamox. The different values we wish&#xD;
      to determine are:&#xD;
&#xD;
        -  Blood-oxygenation-level-Dependent-signal (BOLD-signal) after visual stimulation.&#xD;
&#xD;
        -  Changes in the diameter of a. cerebri media.&#xD;
&#xD;
        -  Changes in the regional and global cerebral blodd flow (CBF) with the help of the&#xD;
           arterial Spin labeling (ASL) method.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Experimental headache models give a unike opportunity to study pathophysiological mechanisms&#xD;
      of prim. headache types such as migraine. Previous studies have used different methods that&#xD;
      have had limitations and none of them have had the opportunity to study neuronal activation.&#xD;
      But that is possible with the application of functional magnetic resonance (fMRI).&#xD;
&#xD;
      Before we apply fMRI to our experimental headache models it is needed to determine how the&#xD;
      BOLD response is influenced and changed by the infusion of different drugs such as the NO&#xD;
      donor Glyceryl Trinitrate (GTN) and Diamox (acetazolamide). It is known that GTN causes&#xD;
      dilation of the cerebral arteries without having any effect on the regional cerebral blood&#xD;
      flow. It is not known what effect GTN has on the BOLD response. Diamox (azetazolamide)&#xD;
      increases the CBF but it is uncertain what effect the drug has on the BOLD response. Previous&#xD;
      studies disagree gravely on this point.&#xD;
&#xD;
      In this study we will be giving infusion of GTN and Diamox in healty subjects to determine:&#xD;
&#xD;
        -  Blood-oxygenation-level-Dependent-signal (BOLD-signal) after visual stimulation.&#xD;
&#xD;
        -  Changes in the diameter of a. cerebri media.&#xD;
&#xD;
        -  Changes in the regional and global cerebral blodd flow (CBF) with the help of the&#xD;
           arterial Spin labeling (ASL) methode.&#xD;
&#xD;
      For the study we will be using a 3-Tesla MRI-scan.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <completion_date>May 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Educational/Counseling/Training</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in BOLD response</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in a. cerebri media diameter</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in CBF</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>headache score</measure>
  </secondary_outcome>
  <enrollment>12</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glyceryl trinitrate, azetazolamide</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy subjects&#xD;
&#xD;
          -  age 18-55 years&#xD;
&#xD;
          -  weight 50-100 kg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Tension type headache more the once per month.&#xD;
&#xD;
          -  other types of headache&#xD;
&#xD;
          -  Daily use of medication other the birthcontrol pills.&#xD;
&#xD;
          -  Pregnant or lactating women.&#xD;
&#xD;
          -  headache on the examination date.&#xD;
&#xD;
          -  contraindications to MRI-scan.&#xD;
&#xD;
          -  hypotension or hypertension.&#xD;
&#xD;
          -  mental illness og substance abuse.&#xD;
&#xD;
          -  other significant conditions determined by the examining doctor.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Messoud Ashina, MD, Phd,</last_name>
    <role>Study Chair</role>
    <affiliation>Danish Headache Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohammad Sohail Asghar, MD</last_name>
    <phone>+4543232161</phone>
    <email>asgsoh01@glostruphosp.kbhamt.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Danish Headache Center</name>
      <address>
        <city>Glostrup</city>
        <zip>2770</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Sohail Asghar, MD</last_name>
      <phone>+4543232161</phone>
      <email>asgsoh01@glostruphosp.kbhamt.dk</email>
    </contact>
    <investigator>
      <last_name>Mohammad Sohail Asghar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2006</verification_date>
  <study_first_submitted>August 11, 2006</study_first_submitted>
  <study_first_submitted_qc>August 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2006</study_first_posted>
  <last_update_submitted>August 11, 2006</last_update_submitted>
  <last_update_submitted_qc>August 11, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2006</last_update_posted>
  <keyword>Healthy subjects</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

